Author

M. Yildirim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Amon· 1 shared A. Bastidas· 1 shared A. Cakir· 1 shared A. Desmond· 1 shared A. G. O. Demir· 1 shared A. Langenbucher· 1 shared A. Mardinoglu· 1 shared B. E. Kerman· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Amon

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

L. Chen, E. Pronk, C. van Dijk, Y. Bian, J. Feyen, T. van Tienhoven, M. Yildirim, P. Pisterzi, M. de Jong, A. Bastidas, R. Hoogenboezem, C. Wevers, E. Bindels, B. Lowenberg, T. Cupedo, , M. Raaijmakers

The paper uses scRNA-seq to analyze signaling between hematopoietic stem/progenitor cells and their niches in AML, identifying inflammatory niche remodeling as a factor affecting tissue failure and patient outcome.

bioRxiv · May 5, 2023 · PreprintCancer Biology

Hexokinase 1b is a novel target for non-small-cell lung cancer

Y. Yozgat, E. Karakoc, O. Sahin, S. Cimen, W. M. Rabeh, M. S. Aydin, A. Mardinoglu, I. Gursel, A. Cakir, O. Sensoy, E. M. Ozdemir, Y. Bayrak, M. Z. Gunluoglu, O. Saatci, J. Jabbar, , M. A. Cevher

This study identifies HK1b as a novel therapeutic target in NSCLC by showing its role in glycolysis, tumor progression, and cisplatin resistance.

bioRxiv · Jun 27, 2022 · PreprintCancer Biology

SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 patients

C. Tastan, B. Yurtsever, G. Sir, D. Dilek Kancagi, S. Demir, S. Abanuz, U. Seyis, M. Yildirim, R. Kuzay, O. Elibol, S. Arbak, M. Acikel Elmas, S. Birdogan, E. Sahin, O. Ozcan, , E. Ovali

The paper isolates and characterizes SARS-CoV-2 from Turkish COVID-19 patients, providing methodology for virus propagation and cell culture tropism.

bioRxiv · Apr 23, 2020Microbiology

Aneuploidy and deregulated DNA damage response define haploinsufficiency in breast tissues of BRCA2 mutation carriers

M. Karaayvaz, R. E. Silberman, A. Langenbucher, S. V. Saladi, K. N. Ross, E. Zarcaro, A. Desmond, M. Yildirim, V. Vivekanandan, H. Ravichandran, R. Mylavagnanam, M. C. Specht, S. Ramaswamy, M. Lawrence, A. Amon, L. W. Ellisen

The paper identifies sub-chromosomal copy number variations and DNA damage in BRCA2 mutation carriers' breast tissues, indicating haploinsufficiency and early carcinogenic changes.

bioRxiv · Aug 8, 2019Cancer Biology